Scientific Papers 10 December 2021 An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic Abstract Global sequencing of genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to reveal new genetic variants that are the key to
pre-print 28 November 2021 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response * Human common cold CoV (hCCCoV) antibodies before and after SARS-CoV-2 infection was assessed * Betacoronavirus hCCCoV antibodies are boosted after SARS-CoV-2 infection * Baseline hCCCoV antibodies do
Scientific Papers 24 May 2021 NEWS2 Score is more accurate than COVID-GRAM for prediction of Critical illness Abstract PURPOSE: Clinical scores to rapidly assess the severity illness of Coronavirus Disease 2019 (COVID-19) could be considered of help for clinicians. Recently, a specific
Scientific Papers 8 May 2020 Innate Immunity against COVID-19 An article published in the Physiological Genomics [https://journals.physiology.org/doi/full/10.1152/physiolgenomics.00033.2020] (American physiological society) suggests immunomodulation through activation
Scientific Papers 5 May 2020 A human monoclonal antibody blocks SARS-CoV-2 in cell culture An article published in Nature Communications [https://www.nature.com/articles/s41467-020-16256-y] reports a recombinantly expressed human chimeric 47D11 H2L2 antibody, reformatted to a fully
Scientific Papers 3 May 2020 Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance Mini-Review published [https://www.sciencedirect.com/science/article/pii/S2052297520300366#bib14] in New Microbes and New Infections [https://www.sciencedirect.com/science/journal/20522975] journal
Scientific Papers 2 May 2020 Temperature and humidity decreases daily new cases and new deaths of COVID-19 Pre-print published [https://www.ncbi.nlm.nih.gov/pubmed/32361460]in the science of the total environment journal [https://www.journals.elsevier.com/science-of-the-total-environment](Elsevier
Scientific Papers 27 April 2020 Entry points of SARS-CoV-2 mapped in study A website 'https://www.covid19cellatlas.org/' provides comprehensive mapping of potential cellular entry of coronaviruses, especially the SARS-CoV-2, which has affinity for the
Scientific Papers 24 April 2020 Chest CT Findings in COVID-19 A study published in Radiology: Cardiothoracic Imaging [https://pubs.rsna.org/doi/10.1148/ryct.2020200110] evaluated the chest CT findings of 104 cases with
Scientific Papers 23 April 2020 Viral dynamics across a spectrum of disease severity in COVID-19 A Letter to the Editor published in the Journal of Infection [https://www.journalofinfection.com/article/S0163-4453(20)30225-5/pdf] reports the "findings of
Scientific Papers 21 April 2020 Presentation & Outcomes Report from 5.7k patients of NYC A study published in the JAMA [https://jamanetwork.com/journals/jama/fullarticle/2765184]reported the characteristics, clinical presentation and outcomes of patients hospitalised with COVID-19
Scientific Papers 16 April 2020 Type 1 interferons as a potential treatment against COVID-19 In a review published in the NEJM [https://www.sciencedirect.com/science/article/pii/S0166354220302059], 'preliminary data concerning the potential activity of type 1
Scientific Papers 15 April 2020 Ventilation as critical as social distancing and hand washing, etc A paper published in NEJM [https://www.sciencedirect.com/science/article/pii/S016041202031254X] advices ventilation as one of the means of removal of virus-laden droplets
Scientific Papers 15 April 2020 Remdesivir is a high potent direct-acting antiviral that inhibits SARS-CoV-2 A scientific paper published in Journal of Biological Chemistry informs that inhibition of RNA-dependent RNA polymerase (RdRp) required for SARS-CoV-2's replication in the
Scientific Papers 14 April 2020 SARS-CoV-2 infects T lymphocytes thro Spike protein A paper published in NATURE [https://www.nature.com/articles/s41423-020-0424-9] reports that the SARS-CoV-2 virus could infect T cells through receptor-dependent, S protein-mediated membrane